This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02753/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/drug/DB02753/identifier/pubchem-compound/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02753/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB02753/identifier/drugbank/

Statements

Subject Item
n2:DB02753
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB02753 n13:DB02753
dcterms:title
Selenoinosine
adms:identifier
n7:46936480 n8:46506447 n9:DB02753 n10:SNI
n3:IUPAC-Name
n4:271B5510-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5516-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5515-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5512-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5513-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5514-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B550E-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B550C-363D-11E5-9242-09173F13E4C5 n4:271B550F-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B550D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B551C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B551D-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5517-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5518-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B551A-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5519-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B551B-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
40093-99-0
n3:Bioavailability
n4:271B5522-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5524-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5525-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5521-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5520-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5523-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5511-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B551E-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B551F-363D-11E5-9242-09173F13E4C5